Imperative Care, Inc. announced the enrollment of the first patient in the prospective observational CLEAR-IT clinical study ...

XCath, a developer of neuroendovascular surgical robotics, announced the completion of the first telerobotic stroke procedure ...

IceCure Medical Ltd. announced positive top-line results from its ICESECRET clinical trial of its ProSense cryoablation ...

Perfuze, an Ireland-based developer of catheters for interventional stroke care, announced it has received FDA 510(k) ...

Nine leading medical societies have issued a call for updated safety standards in fluoroscopy laboratories, where clinicians ...

Abbott announced that its transcatheter Esprit below-the-knee (BTK) everolimus-eluting resorbable scaffold system has been ...

Boston Scientific announced FDA clearance for the “Any Day Dosing” feature on the company’s TheraSphere 360 ytt ...

Terumo Aortic announced that the FDA has granted Breakthrough Device designation for the company’s fenestrated Treo abdomin ...

March 19, 2026—iVascular announced 1-year results from the BARISTA clinical trial, which is evaluating the safety and efficacy of the company&rs ...

Peijia Medical, a China-based domestic medical device company focused on transcatheter valve therapeutics and neurovascular inter ...

March 18, 2026—iVascular announced 3-year follow-up results from the LUMIFOLLOW registry, a large real-world study evaluating ...

Imperative Care, Inc., a developer of treatments for thromboembolic disease, announced the closing of a $100 million ...